How to buy Vigil Neuroscience stock

Vigil Neuroscience is a biotechnology business based in the US. Vigil Neuroscience shares (VIGL) are listed on the NASDAQ and all prices are listed in US Dollars. Vigil Neuroscience employs 52 staff and has a market cap (total outstanding shares value) of 0.00.

Vigil Neuroscience stock price (NASDAQ: VIGL)

Use our graph to track the performance of VIGL stocks over time.

Vigil Neuroscience shares at a glance

• Key figures

Information last updated 2023-02-07.

Latest market close	$12.09
52-week range	$2.18 - $18.27
50-day moving average more info button	$11.66
200-day moving average more info button	$8.35
Wall St. target price	$19.60
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-6.45

Buy Vigil Neuroscience stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Vigil Neuroscience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Vigil Neuroscience price performance over time

Historical closes compared with the close of $12.09 from 2023-02-07

1 week (2023-02-02)	10.31%
1 month (2023-01-09)	0.42%
3 months (2022-11-09)	-1.87%
6 months (2022-08-09)	80.45%

1 year (2022-02-09)	-16.56%
2 years (2021-02-05)	N/A
3 years (2020-02-05)	N/A
5 years (2018-02-05)	N/A

Vigil Neuroscience financials

Gross profit TTM	$0
Return on assets TTM	-41.5%
Return on equity TTM	-77.81%
Profit margin	0%
Book value	$5.79
Market capitalisation more info button	$400.3 million

TTM: trailing 12 months

Vigil Neuroscience share dividends

We're not expecting Vigil Neuroscience to pay a dividend over the next 12 months.

You may also wish to consider:

• Pfizer (PFE.US) (3.75% forward annual dividend yield)

Vigil Neuroscience overview

Vigil Neuroscience, Inc. , a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. It utilizes the tools of neuroscience drug development across multiple therapeutic modalities in its efforts to develop precision-based therapies to improve the lives of patients and families. Its lead candidate is VGL101, a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 proof-of-concept trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also conducting IND-enabling studies with a novel small molecule TREM2 agonist program to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.

Frequently asked questions

What percentage of Vigil Neuroscience is owned by insiders or institutions?
Currently 10.172% of Vigil Neuroscience shares are held by insiders and 87.676% by institutions. How many people work for Vigil Neuroscience?
Latest data suggests 52 work at Vigil Neuroscience. When does the fiscal year end for Vigil Neuroscience?
Vigil Neuroscience's fiscal year ends in December. Where is Vigil Neuroscience based?
Vigil Neuroscience's address is: 1 Broadway, Cambridge, MA, United States, 02142 What is Vigil Neuroscience's ISIN number?
Vigil Neuroscience's international securities identification number is: US92673K1088